Zhou, Z.; Zhao, C.; Li, S.; Han, X.; Zhu, J.; Xue, S.; Li, Z.
BMP2–ERK–ATF4 Axis-Based 6-methoxybenzofuran Compound I-9 Acts as Candidate Drug for Bone Formation and Anti-Osteoporosis. Int. J. Mol. Sci. 2024, 25, 3350.
https://doi.org/10.3390/ijms25063350
AMA Style
Zhou Z, Zhao C, Li S, Han X, Zhu J, Xue S, Li Z.
BMP2–ERK–ATF4 Axis-Based 6-methoxybenzofuran Compound I-9 Acts as Candidate Drug for Bone Formation and Anti-Osteoporosis. International Journal of Molecular Sciences. 2024; 25(6):3350.
https://doi.org/10.3390/ijms25063350
Chicago/Turabian Style
Zhou, Ziying, Chenxi Zhao, Siyan Li, Xiaoyang Han, Jiangyi Zhu, Situ Xue, and Zhuorong Li.
2024. "BMP2–ERK–ATF4 Axis-Based 6-methoxybenzofuran Compound I-9 Acts as Candidate Drug for Bone Formation and Anti-Osteoporosis" International Journal of Molecular Sciences 25, no. 6: 3350.
https://doi.org/10.3390/ijms25063350
APA Style
Zhou, Z., Zhao, C., Li, S., Han, X., Zhu, J., Xue, S., & Li, Z.
(2024). BMP2–ERK–ATF4 Axis-Based 6-methoxybenzofuran Compound I-9 Acts as Candidate Drug for Bone Formation and Anti-Osteoporosis. International Journal of Molecular Sciences, 25(6), 3350.
https://doi.org/10.3390/ijms25063350
